B8C-17920-18612
2 vaccinations
7 coded responses
22 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 483 / MI
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-08
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-12
-
2021-01-13
Survey response — day 7, dose 1MedDRA: Cough — Feeling: Fair · HeadacheFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Anosmia, Arthralgia, Asthenia, Chills, Cough, Diarrhoea, Dysgeusia, Fatigue, Headache, Myalgia, Nasal congestion, Nausea, Pyrexia, SARS-CoV-2 test negative — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Headache nausea diarrhea weakness coughing fever muscle aches joint aches extreme fatigue. Loss of smell. Sour taste chills nasal congestion tested negative for COVID 24 hours after beginning of symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — day 21, dose 1MedDRA: Dyspnoea, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: More nausea and shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-10
- 2021-02-19
-
2021-02-22
Dose 2 — Pfizer-BioNTech
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-03-01
-
2021-03-09
Survey response — day 14, dose 2MedDRA: Headache — Feeling: GoodFree text: Head paioMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-22
- 2021-03-29
-
2021-05-24
Survey response — 3 months, dose 2MedDRA: Hypoaesthesia — Feeling: GoodFree text: Thought it was transitional but hasnt gone away. Numbness of my left hand and foot which comesAndGoesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-02-22
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: FairFree text: Numbness in fingers and toes off and on especially when they get cold ( cold water can do it). Not really new. Had it since I had Covid it just seems worseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Cough
Release 2 — day 14, dose 1
Symptoms: Headache nausea diarrhea weakness coughing fever muscle aches joint aches extreme fatigue. Loss of smell. Sour taste chills nasal congestion tested negative for COVID 24 hours after beginning of symptoms
Release 2 — day 21, dose 1
Symptoms: More nausea and shortness of breath
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 5 — day 14, dose 2
Symptoms: Head paio
Release 8 — 3 months, dose 2
Symptoms: Thought it was transitional but hasnt gone away. Numbness of my left hand and foot which comesAndGoes
Release 11 — 12 months, dose 2
Symptoms: Numbness in fingers and toes off and on especially when they get cold ( cold water can do it). Not really new. Had it since I had Covid it just seems worse
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dysgeusia | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release